Chronic Inflammation Index-Based Tumor Subsite Classification Correlated with Chemotherapy Benefit and Survival Outcomes in Stage II-III Colorectal Cancer
The validated CII represents a biologically relevant, subsite-specific prognostic biomarker in CRC. The chronic inflammation-based tumor subsite classification correlated with chemotherapy efficacy and clinical outcomes, highlighting its potential for personalized treatment strategies.
Authors
- Hou‐Qun Ying (ORCID: https://orcid.org/0000-0003-3858-4761)
- Qiu-Ying Ye
- Xue‐Xin Cheng (ORCID: https://orcid.org/0000-0003-2241-2535)
- Yue Peng (ORCID: https://orcid.org/0000-0002-8541-0265)
- Ying Lu (ORCID: https://orcid.org/0000-0002-3032-0318)
- Ya-Nan Li
- Ou Mei
Institutions
- Shangrao Normal University (CN)
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/jir.s517378
- Citations
- 2
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- National Natural Science Foundation of China
- Nanchang University
- Health Commission of Jiangxi Province